DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
Status:
Terminated
Trial end date:
2008-07-30
Target enrollment:
Participant gender:
Summary
This is a post-authorisation safety study to assess the incidence and severity of all
pre-defined cardiovascular events in patients treated with DYNEPO, as well as to detect &
describe less common adverse drug reactions, and to summarise DYNEPO drug utilisation.